Literature DB >> 7506121

Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene.

T Hara1, A B Bianchi, B R Seizinger, N Kley.   

Abstract

The human neurofibromatosis 2 (NF2) gene has recently been isolated and predicted to encode a novel protein named merlin. Based on its high homology to the moesin-ezrin-radixin family of proteins, it may be involved in mediating interactions between the plasma membrane and the cytoskeleton. Here we report the isolation and characterization of multiple transcript isoforms of the mouse NF2 gene. The full length coding complementary DNA sequence of transcript isoform I is 1788 base pairs in length, shares 90% sequence identity with the human NF2 complementary DNA, and encodes a putative protein of 596 amino acids sharing 98% homology with the human merlin protein. Transcript isoforms II and III carry a 45- and 16-base pair insertion, respectively, at nucleotide 1740 at the 3' end, generated by two different modes of alternative splicing; both insertions introduce premature termination codons. Thus, transcript isoforms II and III predict proteins of 591 and 584 amino acids with altered COOH-termini of more hydrophilic character as compared to isoform I. Northern blot analysis and reverse transcription-polymerase chain reaction analysis indicate that the mouse NF2 gene is widely expressed in different tissue types and that the alternative transcripts are variantly expressed. The results presented here indicate high conservation of the NF2 gene during evolution and suggest a possible role for the COOH-terminus in mouse merlin function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506121

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants.

Authors:  Lorena B Benseñor; Kari Barlan; Sarah E Rice; Richard G Fehon; Vladimir I Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

3.  Eleven novel mutations in the NF2 tumour suppressor gene.

Authors:  D Bourn; G Evans; S Mason; S Tekes; L Trueman; T Strachan
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 4.  Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

Authors:  Ivan Stamenkovic; Qin Yu
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

5.  Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.

Authors:  Kseniya Golovnina; Alexander Blinov; Elena M Akhmametyeva; Leonid V Omelyanchuk; Long-Sheng Chang
Journal:  BMC Evol Biol       Date:  2005-12-02       Impact factor: 3.260

6.  Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family.

Authors:  O Turunen; T Wahlström; A Vaheri
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

7.  In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.

Authors:  Heather S Gavilan; Rima M Kulikauskas; David H Gutmann; Richard G Fehon
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

8.  Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.

Authors:  Andrea Toledo; Elena Grieger; Khalad Karram; Helen Morrison; Stephan L Baader
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.